CN¥ 3.52
Key Takeaways
Risk factor
Strong & resilient to price shocks
Profitability factor
Very low or no dividends
About
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd....
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/
Target Price
The average target price of 002437.SZ is 3.2 and suggests 8% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
